Surgery Partners, Inc. (SGRY)
NASDAQ: SGRY · Real-Time Price · USD
21.95
+0.25 (1.15%)
Jun 27, 2025, 4:00 PM - Market closed
Surgery Partners Market Cap
Surgery Partners has a market cap or net worth of $2.79 billion as of June 27, 2025. Its market cap has decreased by -11.69% in one year.
Market Cap
2.79B
Enterprise Value
6.44B
1-Year Change
-11.69%
Ranking
Category
Stock Price
$21.95
Market Cap Chart
Since October 1, 2015, Surgery Partners's market cap has increased from $872.10M to $2.79B, an increase of 220.34%. That is a compound annual growth rate of 12.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 2.81B | 4.54% |
| Dec 31, 2024 | 2.69B | -33.50% |
| Dec 29, 2023 | 4.05B | 61.47% |
| Dec 30, 2022 | 2.51B | -43.08% |
| Dec 31, 2021 | 4.40B | 200.56% |
| Dec 31, 2020 | 1.46B | 89.02% |
| Dec 31, 2019 | 775.00M | 61.93% |
| Dec 31, 2018 | 478.60M | -18.90% |
| Dec 29, 2017 | 590.10M | -23.22% |
| Dec 30, 2016 | 768.60M | -22.10% |
| Dec 31, 2015 | 986.70M | 13.14% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.81B |
| Johnson & Johnson | 365.75B |
| AbbVie | 329.95B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 274.52B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.56B |
| AstraZeneca | 215.99B |